Credit: Peter Barta, St. Jude Children's Research Hospital
St. Jude Children’s Research Hospital scientists have linked inherited variations in a second gene to reduced tolerance of a key cancer drug. Jun J. Yang, Ph.D., assistant member in the Department of Pharmaceutical Sciences at St. Jude, is the study’s first and corresponding author.